Table.
Future directions and potential research in the investigation of obesity and AF.
Domain | Directions and potential research questions |
---|---|
Epidemiology and phenotype modeling | Diversity of adiposity phenotypes (DEXA, skin caliper measurement, obesity subphenotypes, CT imaging) |
Trajectories of obesity exposure and “obesity-years” | |
Childhood obesity and early-age weight with longitudinal (i.e. multi-decade) AF risk | |
Effect modification and augmented risk from comorbidities | |
Cohort studies and secondary data analysis | Weight loss, i.e. bariatric cohorts, and AF risk assessment |
Effect of weight loss on epicardial adiposity and AF risk | |
Atrial and cardiovascular remodeling | Community- and population-based studies of atrial remodeling and simultaneous biomarker assessment (i.e. adipokines, inflammatory markers) |
Regression (reverse remodeling) following bariatric intervention or weight loss | |
Regression (reverse remodeling) with risk factor amelioration (e.g. OSA treatment) | |
Genetics and genomics | Gene-environment interaction relating obesity-years, genetic expression, and AF risk |
Relation of microRNA expression in AF to obesity-years |
AF indicates atrial fibrillation; DEXA, dual-energy X-ray absorptiometry; CT, computerized tomography; OSA, obstructive sleep apnea.